These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28128855)

  • 41. Estimation of a benchmark dose in the presence or absence of hormesis using posterior averaging.
    Kim SB; Bartell SM; Gillen DL
    Risk Anal; 2015 Mar; 35(3):396-408. PubMed ID: 25384940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physical models and limits of radionuclides for decorative building materials.
    Mao Y; Liu Y; Fu Y; Lin L
    Health Phys; 2006 May; 90(5):471-6. PubMed ID: 16607178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of three methods for calculating confidence intervals for the benchmark dose.
    Moerbeek M; Piersma AH; Slob W
    Risk Anal; 2004 Feb; 24(1):31-40. PubMed ID: 15027998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk/benefit assessments of human diseases: optimum dose for intervention.
    Gaylor DW
    Risk Anal; 2005 Feb; 25(1):161-8. PubMed ID: 15787765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Monte Carlo based method to estimate radiation dose from multidetector CT (MDCT): cylindrical and anthropomorphic phantoms.
    DeMarco JJ; Cagnon CH; Cody DD; Stevens DM; McCollough CH; O'Daniel J; McNitt-Gray MF
    Phys Med Biol; 2005 Sep; 50(17):3989-4004. PubMed ID: 16177525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. OptBand: optimization-based confidence bands for functions to characterize time-to-event distributions.
    Chen T; Tracy S; Uno H
    Lifetime Data Anal; 2021 Jul; 27(3):481-498. PubMed ID: 33847858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of data transformations on concentration-response modeling.
    Weimer M; Jiang X; Ponta O; Stanzel S; Freyberger A; Kopp-Schneider A
    Toxicol Lett; 2012 Sep; 213(2):292-8. PubMed ID: 22828011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outlier robust nonlinear mixed model estimation.
    Williams JD; Birch JB; Abdel-Salam AS
    Stat Med; 2015 Apr; 34(8):1304-16. PubMed ID: 25581342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimation of the treatment effect under an incomplete block crossover design in binary data - A conditional likelihood approach.
    Lui KJ
    Stat Methods Med Res; 2017 Oct; 26(5):2197-2209. PubMed ID: 26184831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The log multinomial regression model for nominal outcomes with more than two attributes.
    Blizzard L; Hosmer DW
    Biom J; 2007 Dec; 49(6):889-902. PubMed ID: 17849384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A procedure for developing risk-based reference doses.
    Gaylor DW; Kodell RL
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testing equality and interval estimation in binary responses when high dose cannot be used first under a three-period crossover design.
    Lui KJ; Chang KC
    J Biopharm Stat; 2015; 25(1):190-205. PubMed ID: 24836857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data.
    Bieler GS; Brown GG; Williams RL; Brogan DJ
    Am J Epidemiol; 2010 Mar; 171(5):618-23. PubMed ID: 20133516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current modeling practice may lead to falsely high benchmark dose estimates.
    Ringblom J; Johanson G; Öberg M
    Regul Toxicol Pharmacol; 2014 Jul; 69(2):171-7. PubMed ID: 24662478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of statistical methods for left-censored environmental data with nonuniform detection limits.
    Sinha P; Lambert MB; Trumbull VL
    Environ Toxicol Chem; 2006 Sep; 25(9):2533-40. PubMed ID: 16986810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using the bootstrap to improve estimation and confidence intervals for regression coefficients selected using backwards variable elimination.
    Austin PC
    Stat Med; 2008 Jul; 27(17):3286-300. PubMed ID: 17940997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Confidence sets for a level set in linear regression.
    Wan F; Liu W; Bretz F
    Stat Med; 2024 Mar; 43(6):1103-1118. PubMed ID: 38183296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bayesian dose-response analysis for epidemiological studies with complex uncertainty in dose estimation.
    Kwon D; Hoffman FO; Moroz BE; Simon SL
    Stat Med; 2016 Feb; 35(3):399-423. PubMed ID: 26365692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of available benchmark dose softwares and models using trichloroethylene as a model substance.
    Falk Filipsson A; Victorin K
    Regul Toxicol Pharmacol; 2003 Jun; 37(3):343-55. PubMed ID: 12758215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Benchmark experiment to verify radiation transport calculations for dosimetry in radiation therapy].
    Renner F
    Z Med Phys; 2016 Sep; 26(3):209-23. PubMed ID: 26422577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.